SAR439459
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SAR439459, covering 2024-08-07 to 2025-09-11. Get the full timeline:
Most recent: Clinical Trial Update: Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI) [Phase 1]